Life two years after cancer diagnosis (VICAN) - 2012
Machine translation
Some metadata is not available in this language. The original text is shown and flagged.
Summary
To ensure a better quality of life and to organise appropriate medical follow-up for people with cancer, it is necessary to know more about the persistent physical and psychological effects in the medium and long term and to describe the social consequences. It is from this perspective that a second national survey on cancer survivors two years after diagnosis was designed in France, by INSERM UMR 912, under the auspices of INCa. The choice to consider the two-year period after diagnosis makes it possible to situate the field of investigation in the context of the "survival" time, i.e. beyond the acute treatment phase, varying according to the location but in most cases not exceeding the first 12 months after diagnosis. This two-year interval is also adapted to the survival rates observed for a large number of locations regardless of the level of prognosis (good, intermediate or bad), and allows in particular to focus on intermediate or bad prognosis locations. This project is therefore consistent with all the research carried out today in various countries on the question of the health and living conditions of people with cancer, but is also in line with the first French national survey on this subject carried out in 2004 under the auspices of DREES. The survey pursued two main objectives. The first objective is the evaluation of the second cancer plan, and this survey is included in the actions planned for this second cancer plan. The second objective is in line with the research areas mentioned above: it is to determine the nature, prevalence and temporality of physical, psychological and social factors that may affect living conditions, social reintegration and (re)integration into work of cancer patients two years after diagnosis, given that the second survey focused on the question of (re)integration into work.
Machine translation
French title
La vie deux ans après un diagnostic de cancer (VICAN) - 2012
Topics
Keywords
Bibliographic citation
doi:10.13144/lil-0967 La vie deux ans après un diagnostic de cancer (VICAN) - 2012 - INSERM, INCa (producteurs), PROGEDO-ADISP (diffuseur).
Record production date
2012
Producers
- Institut national de la santé et de la recherche médicale (INSERM)
Distributor
- Archives de Données Issues de la Statistique Publique (ADISP) (Progedo-Adisp)Quetelet-Progedohttp://www.progedo-adisp.fr
Record version
Version 1 (30/06/2015): documentation of the upper part and publication. Version 1b (23/07/2015): nesstarisation of variables. Version 2 (28/07/2015): version 2 of the survey. Version 2b (15/05/2025): Harmonisation of documentation for the Data Catalogue.
Version date : May 15, 2025
Details
Parallel titles
- Life two years after cancer diagnosis (VICAN) - 2012
Country
- France (FR)
Geographic coverage
- Metropolitan France
Geographic unit : Municipality
Analysis unit
- Individual
Data type
- Individual survey data
Study population
The target population is the same as in the first national survey in 2004, i.e. persons aged 18 and over, for whom a cancer diagnosis was made two years prior to the survey. In France, the registers of cancer incidents are not exhaustive, both in terms of their geographical coverage and the cancer locations concerned. The Long Term Disorders (ALD) directory managed by the Sickness Insurance is therefore the only national source for the almost exhaustive census of cancer incidents, since this pathology allows insured persons affected by it to benefit from 100% coverage, knowing that the French health insurance system is a caisse system which relies on many schemes with a management delegation. For the sake of efficiency, only insured persons covered by the three main schemes will be considered as a national sample. The three schemes which manage benefits for almost the entire French population are: the general scheme (Caisse Nationale de l'Assurance Maladie des Travailleurs Salariés or CNAMTS), the agricultural scheme (Mutualité Sociale Agricole or MSA) and the self-employed scheme (Régime Social des Indépendants or RSI). With regard to the restriction of the cancer location studied, the VICAN study project limited its ambitions by making a reasoned choice according to four criteria: the frequency of cancer location, the survival rate at two years, the specificity of the age groups concerned and the scientific interest (state of knowledge in international medical literature, evolution and standardisation of care protocols, increase in incidence in certain groups, influence of social inequalities in health...). Twelve locations were selected: · 4 "good prognosis" locations (cancer of breast, prostate, thyroid, melanoma); · 7 so-called "intermediate prognosis" locations (colon-rectum cancer, Superior Aero-Digestive Path cancer, bladder cancer, kidney cancer, non-Hodgkin's lymphoma (LMNH), uterine body cancer and cervical cancer; · 1 location called "bad prognosis" (lung cancer). Social insured persons under the general scheme (CNAMTS), the agricultural scheme (MSA) or the self-employed scheme (RSI) who were registered as having a long-term disorder two years prior to the start of the survey for an initial cancer concerning one of the above-mentioned locations are therefore covered.
Collection dates
- Feb 1, 2012 Start
- Jun 30, 2013 End
Methodology
Time method of the data collection
- Cross-sectional survey
Sampling procedure
- The foundation of the sampling frame was made by random drawing with uneven probabilities. The sampling plan developed takes into account both the desired numbers for each stratum (by location and age group, numbers and survival rates observed in the insured population (INSEE15, InVS16 and Inca17), and the response rates obtained in the first survey. The sampling plan is stratified by age (two subsamples 18-52 years / 53-82 years of age on diagnosis) and with uneven probabilities in order to over-represent the least common cancer locations among those selected. It uses a series of projections based on some available data: 1. Annual incidence by age and sex for each location (InVS), 2. Age and gender structure of the French metropolitan population (INSEE), 3. Survival after cancer by location, all stages at detection combined (INCA), 4. Response rate by location obtained in 2004 (ALD-2004). Sample 1 brings together insured persons between 18 and 52 years of age at the time of diagnosis with an ALD for one of the 9 locations considered in this age group: breast, skin-melanoma, thyroid, Colon-Rectum, VADS, Rein, LMNH, cervix, lung. Sample 2 brings together insured persons between 53 and 82 years of age at the time of diagnosis with an ALD setting for one of the 11 locations considered in this age group: breast, prostate, skin-melanoma, Colon-Rectum, VADS, Vessie, Rein, LMNH, cervical, uterine body, lung.
Data collector : Plateforme d’enquêtes de l'ORS PACA-Inserm U912
Data collection method : Patient data were collected during telephone interviews using the CATI (Computer Assisted Telephone Interview) method. The clinical and medical data on the cancer location and specific care provided were collected by paper questionnaires from the medical teams designated by the patient as having initiated his long-term condition (ALD).
Type of research instrument : Directive
Characteristics of the data collection situation : Interview duration: 40 minutes.
Processings
Response rate(s) : The response rate calculated according to the standards and standards defined by the American Association for Public Opinion Research (AAPOR) is 43% in sample 1 (18-52 years) and 44% in sample 2 (53-82 years).
Weighting : The data are weighted to be representative of the target population (base population). In order to minimise bias due to non-response, the data are rectified ex-post.
Variables
The full list of variables, with question, universe and statistics, is paged on a dedicated page.
Data
Documentation
Documents
No attached document in the record.
Downloadable resources (questionnaires, codebooks, etc.)
- Questionnaire patient
- Questionnaire médecin - Colon-rectum
- Questionnaire médecin - Lymphomes malins non hodgkiniens (LMNH)
- Questionnaire médecin - Mélanome
- Questionnaire médecin - Poumon
- Questionnaire médecin - Prostate
- Questionnaire médecin - Rein
- Questionnaire médecin - Sein
- Questionnaire médecin - Thyroide
- Questionnaire médecin - Utérus
- Questionnaire médecin - Voies aéro-digestives supérieures (VADS)
- Questionnaire médecin - Vessie
- Dictionnaire des variables
Data access
STD Standard files
STD : Les fichiers Standard (STD) sont des données anonymisées accessibles aux demandeurs qui appartiennent à la communauté scientifique (cf. section "Restrictions").
Number of files : 1 data file
Request portal
- Quetelet-Progedo data request portal
Access notes
- The data are available in SAS, SPSS, STATA and CSV formats.
Contact
- Adisp team
Archive originally storing the data
ADISP - Archives de Données Issues de la Statistique Publique
Confidentiality agreement
To obtain the data, the user must first submit a request using the Quetelet-Progedo-Diffusion data request portal; approval is subject to the user's status, as well as the presence of an institutional e-mail address and a research project. If a request is approved, an individualised agreement with ADISP (and in the case of FPR, a confidentiality agreement with the Statistical Confidentiality Committee) must be signed. Such agreements will require the user to adhere to the following conditions: -To use the data exclusively for research purposes; -Not to transfer the data, in any form whatsoever, to a third party, whether free of charge or for a fee; -To process these data in accordance with rules of art and statistical secrecy; -To mention the data source in their communications, publications, etc., according to the citation to be used whenever re-using the data (see below); -To inform the data distributor of any communications, publications, etc. they produce and to send the data distributor the references; -To inform the data distributor of any findings related to data quality or difficulties in re-use; -To inform the data distributor of any data re-use for research other than what was specified above; -To destroy the data files once the research has been completed; -To respect the regulations on the protection of personal data.
Restrictions
Files disseminated via Quetelet-Progedo-Diffusion are accessible to French and international researchers, doctoral students, post-doctoral students, and master's students for the purposes of research, scientific production and in some cases teaching. Any commercial use is prohibited. The term, "for the purposes of research," is defined as any scientific production or reproduction that validates new general knowledge. The results must be made public and free to disseminate.
Terms of use
The user must submit a request using the Quetelet-Progedo-Diffusion data request portal; approval is subject to the user's status, as well as the presence of an institutional e-mail address and a research project. If a request is approved, an individualised agreement with ADISP (and in the case of FPR, a confidentiality agreement with the Statistical Confidentiality Committee) must be signed. If the data are to be analysed by a team, all members of the research team must apply for access.
Required citation
doi:10.13144/lil-0967 La vie deux ans après un diagnostic de cancer (VICAN) - 2012 - INSERM, INCa (producteurs), PROGEDO-ADISP (diffuseur).
Publication deposit
In order to provide the data producer(s) with essential information concerning how their data is being re-used, data users are required to notify ADISP (diffusion.adisp@cnrs.fr) of any publication produced as a result of exploiting the survey data, by sending, whenever possible electronically, the bibliographic reference and abstract.
Disclaimer
The data producer and data distributor cannot be held responsible for any interpretations or conclusions resulting from the re-use of the data.